About Genvax Technologies
Genvax Technologies is a private company based in Ames, Iowa, incorporated in 2021 in Delaware. It has reported $9,769,985 raised in two offerings on Form D since August 2022. Its chief executive is Joel Harris.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 7, 2024 | Jun 24, 2024 | $3,399,985of $5.2M target | 9 | $377K | EquityRule 506(b) | Form D ↗ |
| Jun 2, 2022 | Aug 9, 2022 | $6,370,000fully sold | 20 | $318K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $9,769,985 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Genvax Technologies's Form D filed Jun 24, 2024.
Earlier filings also listed Scott Holmstrom (director, last listed Aug 2022).